Please provide your email address to receive an email when new articles are posted on . Monoclonal antibodies decrease inflammation in the immune system by binding to ...
People with rheumatoid arthritis usually depend on drugs to control pain in their joints. But this summer, the Food and Drug Administration approved a different sort of treatment. It's a device that ...
—Investigators conducted a secondary analysis of the TARGET trial to determine differences in cardiovascular risk between rheumatoid arthritis patients treated with triple therapy or tumor necrosis ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In your journey ...
TOKYO, Sept 26, 2022 - (JCN Newswire) - - Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac Gesellschaft fur klinische Spezialpraparate mbH announced today that they have obtained ...
Whether you are seeking information for yourself or a loved one, read on to learn more about the disease and how to better understand its signs and symptoms. Rheumatoid arthritis is an inflammatory ...
Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests. Changes in the gut microbiome before ...
Arthritis is a complex and often misunderstood condition that affects millions of individuals worldwide. It is not a single disease but rather an umbrella term that encompasses over 100 types of joint ...
A 1-year course of methotrexate (MTX) in clinically suspected arthralgia may prevent the development of rheumatoid arthritis (RA) in at-risk individuals who test negative for anti-citrullinated ...
Peripheral neuropathy can develop as a complication of rheumatoid arthritis (RA). You may find similar treatments for both, but your doctor is best equipped to determine what medications may work for ...
A new therapeutic approach for rheumatoid arthritis (RA) could help prolong the time between flare-ups and even prevent the onset of the disease in at-risk patients. This is the promise of a new study ...
Methotrexate belongs to a class of drugs called antimetabolites. This type of drug slows the growth of skin cells or cancer cells and suppresses the immune system. In addition to treating rheumatoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results